Surrey Heartlands

Joint Formulary & PAD

Glycopyrronium (Seebri Breezhaler) - Chronic Obstructive Pulmonary Disease (COPD)

You are here : Home > Formulary Search > Glycopyrronium (Seebri Breezhaler) - Chronic Obstructive Pulmonary Disease (COPD)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green (see narrative)
Formulations :
  • Inhaler (dry powder)
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines BNF SPC
Restrictions / Comments :

Documentation

Guidelines (Local)
In-Check device for improving inhaler technique - Nov 16
Guidelines (Local)
COPD Primary Care Medicines Management Guidelines - updated Jun 23
Webpage
How to use a Breezhaler inhaler - video
Patient resource
How to use a Breezhaler inhaler - Patient information leaflet

PAD Profile

ChemicalSubstance :
Glycopyrronium (Seebri Breezhaler)
Indication :
Chronic Obstructive Pulmonary Disease (COPD)
Group Name :
LAMA
Keywords :
LAMAs, antimuscarinic bronchodilators, respiratory, long-acting muscarinic antagonist
Brand Names Include :
Seebri Breezhaler
Important Information :

Second line - low resistance inhaler. With low-resistance devices, patients must inhale faster to generate the power to separate the drug molecules, which may be difficult in patients with poor lung function.

Combination with LABA recommended in COPD.

Prescribe by BRAND

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Chronic Obstructive Pulmonary Disease (COPD)
Supporting Documents :
4

Other Indications

Below are listed other indications that Glycopyrronium (Seebri Breezhaler) is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Chronic Obstructive Pulmonary Disease (COPD).

Committee Recommendations (1)

04 Mar 20 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

The locally preferred LAMA devices are as follows:

  • Spiriva Respimat (tiotropium soft mist inhaler). Re-usable device.
  • Incruse Ellipta (Umeclidinium DPI)
  • Seebri Breezhaler (Glycopyrronium DPI)
  • Eklira Genuair (Aclidinium DPI)

Devices should be prescribed by BRAND

See full COPD guidelines for more information